After the intervention, BCSs lost 1.6 kg (p < 0.01) of body weight, 1.8 kg (p < 0.01) of RFM, 3 cm (p < 0.01) of waist circumference, and 2.4 cm (p < 0.01) of hip circumference, while no changes were observed in fat-free mass (p = 0.6) and arm bone-free muscle area (p = 0.7). Thirty-three BCSs completed the study and 91% of them presented obesity or overweight at baseline. Nutrition plans were based on the dynamic macronutrient meal-equivalent menu method (MEM) and dietary guidelines for BCSs. RFM was assessed at baseline and after the 3-month nutrition intervention. Studying the effect of an individualized nutrition intervention according to socioeconomic status and grocery shopping behavior on BCSs relative fat mass (RFM).īCSs attending an academic medical center were studied participants saved all 1-week supermarket tickets and answered a grocery shopping consumer preference survey. Since over half of the women approached for this intervention study refused on the basis of time and travel requirements, interventions that utilize home-based approaches may be necessary to reach greater numbers and a greater diversity of patients.īody composition assessment in breast cancer survivors (BCSs) is essential to plan feasible dietary strategies for sarcopenic obesity prevention. CONCLUSION: Data from this pilot study suggest that exercise/diet interventions may yield promise in preventing adverse chemotherapy-induced weight and body composition changes among young women who receive adjuvant chemotherapy for breast cancer, and that further study is needed. RESULTS: Mean changes (SE) in body weight and composition at 6 month follow-up were as follows among historic patient controls and intervention participants, respectively: body weight +2.2(.4) kg vs. Data from patients participating in the intervention (N=9) were compared to data from historic patient controls (N=36). Dual energy x-ray absorptiometry was used to assess body composition at both baseline and at six-month follow-up. METHODS: We explored whether a clinic-based exercise program, which promoted a specialized program of strength training, aerobic activity and a healthful (</=20% fat fruit, vegetable and calcium-rich) diet could prevent body composition change among Stage I/II premenopausal breast cancer patients who would receive adjuvant chemotherapy. These body composition changes become apparent within six months of diagnosis. This weight gain also is unique, since patients lose lean body mass while they gain weight. PURPOSE: Weight gain is a common side effect of adjuvant chemotherapy for breast cancer - a side effect that decreases quality of life and also may decrease both disease-free and overall survival.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |